Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study (Q44511561)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study |
scientific article |
Statements
1 reference
Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study (English)
1 reference
Norihiro Nishimoto
1 reference
Kazuyuki Yoshizaki
1 reference
Keiji Maeda
1 reference
Taro Kuritani
1 reference
Hitoshi Deguchi
1 reference
Bunzo Sato
1 reference
Nobuyuki Imai
1 reference
Masaki Suemura
1 reference
Takahiro Kakehi
1 reference
Nobuhiro Takagi
1 reference
Tadamitsu Kishimoto
1 reference
1 July 2003
1 reference
1 reference
30
1 reference
7
1 reference
1426-1435
1 reference
Identifiers
1 reference